Evofem Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PRNewsWire • 08/21/20
Do Options Traders Know Something About Evofem Biosciences (EVFM) Stock We Don't?Zacks Investment Research • 08/11/20
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/04/20
Evofem Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate UpdatePRNewsWire • 08/04/20
Are Options Traders Betting on a Big Move in Evofem Biosciences (EVFM) Stock?Zacks Investment Research • 06/29/20
Evofem Biosciences (EVFM) Looks Good: Stock Adds 10.1% in SessionZacks Investment Research • 06/26/20
Evofem Announces Pricing of Approximately $100 Million Public Offering of Common StockPRNewsWire • 06/03/20
U.S. FDA Approves Evofem Biosciences' Phexxi™ (lactic acid, citric acid and potassium bitartrate), the First and Only Non-Hormonal Prescription Gel for the Prevention of PregnancyPRNewsWire • 05/22/20
PDL BioPharma Completes Distribution of Evofem Biosciences Common Stock to PDL StockholdersPRNewsWire • 05/21/20
PDL BioPharma Declares Distribution Ratio for Dividend of Evofem Biosciences Common Stock to PDL StockholdersPRNewsWire • 05/18/20
Evofem Biosciences Inc. (EVFM) CEO Saundra Pelletier on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/07/20
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/12/20